The invention is directed to 2-aryl hydrazonopropanals that exert anti-tumor activity and methods for using them to prevent, inhibit and treat cancer. It also involves anti-tumor compositions containing these 2-aryl hydrazonopropanals, and methods of treatment using these compositions.
展开▼